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Purpose: To investigate the sleep quality of patients with type 2 diabetes (T2D) and its
impact on glycaemic control.
Methods: Using a convenience sampling method, 220 patients with T2D were recruited. The
Pittsburgh Sleep Quality Index (PSQI) was used to evaluate the sleep quality with threshold
at PSQI  8. The glycosylated haemoglobin A1c (HbA1c) test was used to measure the
glycaemic control with threshold at HbA1c < 7%.
Results: The PSQI score was 8.30 ± 4.12. The sleep disorder incidence rate was 47.1%. Pa-
tients with HbA1c  7% had significantly lower PSQI global and factor scores (p < 0.01)
versus the control group. Sleep latency, sleep disturbance, and daytime dysfunction were
the risk factors for poor glycaemic control.
Conclusion: Patients with T2D have high sleep disorder rate negatively impacting glycaemic
control. Health care providers should pay close attention to the sleep quality of T2D pa-
tients, and provide them with appropriate educational material.
Copyright © 2014, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. All rights reserved.1. Introduction
Diabetes mellitus is a common metabolic disease. By year
2035, it estimated that 592million people across the world will
live with diabetes [1]. Type 2 diabetes currently accounts for
95% of all of diagnosed diabetes [2]. In China, the incidence of
diabetes is high at 9.75% [3], exerting vast burden on the in-
dividuals, families, and society [4]. Multiple studies have
recognized sleep disorder a novel risk factor for diabetes [5,6].
The sleep disorder plays a pivotal role in the occurrence and(X.-M. Li).
Nursing Association
g Association. Productiondevelopment of diabetes via neuro e endocrine metabolic
pathway [7]. People suffering from a sleep disorder e sleep
quality or sleep quantity are impaired e experience reduction
in the insulin sensitivity and consequently, elevated blood
glucose, aggravating the progress of diabetes. On the other
hand, sleep disorder can facilitate the hypothal-
amicepituitaryeadrenocortical system to release extra
glucocorticoid. As a result, the glucose production increases,
while the consumption decreases, affecting the glycaemic
control [8,9]. Therefore, good sleep quality is crucial for
maintaining an effective glycaemic control and improving theand hosting by Elsevier (Singapore) Pte Ltd. All rights reserved.
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majority of the current sleep studies in diabetic patients focus
on obstructive sleep respiratory disease. Some studies
deployed complex evaluation methods which are difficult to
use pervasively in practice. Furthermore, there have been only
a few domestic studies addressing the role of sleep disorder in
diabetic patients, and their generalization has been restricted
due to the singleness of subjects, who were either senior cit-
izens or females. The aim of our study was to reveal further
evidence verifying the relationship between sleep and gly-
caemic control. The sleep quality and its impact on glycaemic
control in patients with type 2 diabetes were analysed,
thereby laying foundation for corresponding interventions in
practice.2. Subjects and methods
2.1. Subjects
A total of 220 patients was administered in the Department of
Endocrinology in the 1st and 2nd Affiliated Hospital of Xi'an
Jiaotong University during September, 2013 and January, 2014.
Participants were selected using convenience sampling
method, and the sample size was determined using the
observational study formulae [10]. The inclusion criteria were:
a) meet the diagnostic criteria for type 2 diabetes (symptoms
of diabetes þ fasting plasma glucose (FPG)  7.0 mmol/L) [11],
b) symptoms of diabetes and 2 h postprandial plasma glucose
(2hPG)  11.1 mmol/L, c) symptoms of diabetes and random
plasma glucose  11.1 mmol/L, d) over 18 years old with dia-
betes duration > 1 year. Patients were excluded if they had
type 1 diabetes, gestational diabetes, or other specific types of
diabetes, as were the patients with acute diabetic complica-
tions, severe heart diseases, lung diseases, and cerebral dis-
eases. Those with mental illness or family history of mental
illness, and those with intelligence or cognitive impairment
were also excluded from this study.
2.2. Study tools
2.2.1. General information questionnaire
Using literature search, clinical and research experts, a
questionnaire was developed, modified, and improved. Par-
ticipants' demographic information such as gender, age, ed-
ucation, marital status, and life style (smoking, drinking and
exercise) were evaluated. Additionally, data on chronic dia-
betic complications and family history were collected to
assess their disease status. Physiological and biochemical in-
dicators such as HbA1c and body mass index (BMI) were ob-
tained using this questionnaire.
2.2.2. Pittsburgh sleep quality index (PSQI)
PSQI is a self-rating scale developed by Buysse et al., in 1989
[12]. The scale was translated into Chinese by Xian-Chen Liu
to evaluate the sleep quality. A total of 19 self-rating items
were categorized into seven factors, all subjective, sleep
quality, sleep latency, sleep duration, sleep efficiency, sleep
disturbance, use of sleeping medications, and daytime
dysfunction. Each factor was scored from 0 to 3. The sum ofthe scores for the seven factors yields PSQI global score, which
ranges from 0 to 21. Higher the PSQI global score, poorer the
sleep quality. PSQI has been used widely in multiple pop-
ulations, and has shown a good internal consistency, test-
retest reliability, construct validity, and empirical validity. In
a study carried out by Xian-Chen Liu [13], the Cronbach'a co-
efficient of PSQI was 0.84, the split half reliability was 0.87, and
a 2-week test-retest reliability was 0.81. The cut-off PSQI score
was 8, the sensitivity was 98.3%, and the specificity was
90.2%. Therefore, PSQI 8 was used as an indication of the
presence of sleep disorder in this study.
2.3. Data collection
The study protocol was approved by the Ethics Committee of
the Xi'an Jiaotong University and was conducted in accor-
dance with the Declaration of Helsinki. All participants pro-
vided a written informed consent.
2.3.1. Questionnaires
A total of 220 questionnaires were handed out. Systematically
trained investigators carried out unified interviews. The face-
to-face interviews and the questionnaires were completed
independently by the participants per se. The participants un-
able to complete the questionnaire by themselves were asked
item by item orally by the investigators. The investigators
recorded the answers truthfully. If any questions arose during
the interview, the investigators provided an explanation or
clarification to a participant. Once completed the question-
naires were recovered. Any missing parts were supplemented
by the patients to ensure the consistent data quality.
2.3.2. Physiological and biochemical indicators
Participants' height, weight, and blood pressure were
measured on the first day of being admitted. The HbA1c level
(using high pressure liquid chromatography) and liver func-
tion were evaluated under fasting state for at least 10 h. Pa-
rameters reflecting liver function such as total cholesterol
(TC), triglyceride (TG), high density lipoprotein cholesterol
(HDL-C), and low density lipoprotein cholesterol (LDL-C) were
measured using the ADVIA® 2400 automatic biochemical
analyser (Siemens, Berlin, Germany). The fingertip blood
samples were collected to assess FPG and 2hPG (OneTouch®
UltraVue, Johnson, America). According to the American
Diabetes Association guidelines for 2010 [14], HbA1c < 7% is
considered to be a good glycaemic control.
2.4. Statistical analysis
Dataweremanaged using Epi Info 7 software and double entry
method was used to ensure the quality. Statistical analysis
was conducted using SPSS version 13.0 software (SPSS Inc.,
Chicago, IL, USA). Frequency, percentage, and
mean ± standard deviation were used for statistical descrip-
tion. The independent-samples t test, nonparametric Man-
neWhitney U-test, and c2 test were performed for statistical
inference. Finally, a logistic regressionmodel was established,
using PSQI factor scores as independent variables and HbA1c
as dependent variables. Values of p < 0.05 were considered
statistically significant.
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3.1. General information
Overall, 14 participants were excluded from the analysis due
to lack of data, resulting in the final number of analysed
questionnaires to be 206. The age range was from 25 to 80
years (57.23 ± 11.24 years). Of 206 participants, 136 (66.0%)
were males. The average duration of diabetes was 9.77 ± 6.72
years. The number of patients under insulin treatment was
123 (60.0%). There were 63/206 (30.6%) smokers and 31/206
(15.0%) drinkers. There were 90/206 (43.7%) patients with
family history of diabetes.
3.2. Comparison of the general information between
good sleepers and poor sleepers
According to the PSQI global score, patients were categorized
into poor sleepers (PSQI 8) and good sleepers (PSQI < 8). Poor
sleepers accounted for 47.1%, and their diabetes duration, age,
FPG, 2hPG, and HbA1c were significantly higher than in good
sleepers (p < 0.05). Additionally, the percentage of patients
using insulin in the poor sleepers group was significantly
higher than in the good sleepers group (c2 ¼ 5.29, p < 0.05). As
is shown in Table 1, there were no statistical differences be-
tween the two groups in terms of other indicators.
3.3. Relationship between glycaemic control and PSQI
score
Patients were categorized into either a good glycaemic control
group (HbA1c < 7%) or a poor glycaemic control group
(HbA1c  7%) based on their HbA1c. The average PSQI globalTable 1 e Comparison of good sleepers and poor sleepers (n/m
Item Poor sleeper (n ¼ 97) Good sleepe
Age (year) 59.48 ± 11.19 55.23 ±
BMI (kg/cm2) 24.36 ± 3.86 24.40 ±
Family history 43 47
Smoking 28 35
Drinking 13 18
Use of insulin 66 57
Blood glucose monitoring 71 89
Exercise 69 86
Diabetic foot 8 4
Diabetic neuropathy 43 46
Diabetes duration 10.98 ± 7.47 8.70 ± 5
Systolic BP (mmHg) 134.42 ± 15.68 134.91 ±
Diastolic BP (mmHg) 78.56 ± 10.37 80.48 ±
TC (mmol/L) 4.69 ± 1.42 1.48 ± 1
TG (mmol/L) 2.19 ± 2.02 2.01 ± 1
HDL-C (mmol/L) 1.14 ± 0.34 1.09 ± 0
LDL-C (mmol/L) 2.81 ± 1.02 2.73 ± 0
FPB (mmol/L) 8.70 ± 2.19 7.80 ± 2
2hPB (mmol/L) 13.89 ± 3.38 12.53 ±
HbA1c (%) 9.15 ± 2.08 7.92 ± 1
n ¼ number of participants; SD ¼ standard deviation.
*p < 0.05; **p < 0.01.
a ManneWhitney U-test.
b c2 test; the remaining used the independent-samples t test.score was 8.30 ± 4.12, and only 50 (24.3%) patients maintained
good glycaemic control. Those with good glycaemic control
had an average PSQI global score of 4.96 ± 2.46 which was
significantly lower than that of the patients with poor gly-
caemic control (Z ¼ 7.08, p < 0.01) (Table 2). There were sta-
tistical differences between these two groups in terms of six
PSQI factors, except for the “use of sleeping medications”.3.4. The impact of sleep quality on glycaemic control in
patients with type 2 diabetes
Logistic regression analyses were conducted to examine the
association between glycaemic control and the PSQI score.
After adjusting for gender, age, diabetes duration, use of in-
sulin, diabetic feet, and diabetic neuropathy, the final model
was established (Table 3). Sleep latency, sleep disturbance,
and daytime dysfunction were risk factors for poor glycaemic
control (HbA1c  7%). The ORs (95% CI) for each factor were
2.14 (1.26e3.69), 5.09 (1.48e17.52), and 3.50 (2.02e6.07),
respectively.4. Discussions
4.1. Sleep quality of patients with type 2 diabetes
Sleep can be influenced by various factors. Sleep disorder is
commonly seen nowadays with reported <10% of the general
population suffering from at least one form of sleep disorders
[15]. When it comes to people with type 2 diabetes, the inci-
dence of sleep disorder is even more of a concern. So far,
there have been a variety of methods available for sleep
evaluation, among which PSQI is the most widely used due toean ± SD)
r (n ¼ 109) Overall (n ¼ 206) Test statistic p value
10.95 57.23 ± 11.24 2.76 0.006**
3.33 24.38 ± 3.58 0.09 0.927
90 0.03b 0.864
63 0.25b 0.614
31 0.39b 0.533
123 5.29b 0.021*
160 2.12b 0.146
155 1.67b 0.197
12 1.96b 0.161
89 0.10b 0.758
.80 9.77 ± 6.72 2.18a 0.014*
19.59 134.68 ± 17.81 0.20 0.846
10.62 79.57 ± 10.52 1.17a 0.241
.04 4.58 ± 1.24 1.23 0.221
.80 2.09 ± 1.90 0.82a 0.412
.31 1.11 ± 0.33 1.26a 0.213
.76 2.77 ± 0.89 0.62 0.534
.23 8.22 ± 2.26 2.92 0.004**
3.23 13.17 ± 3.16 2.93 0.004**
.92 8.50 ± 2.09 4.40 0.001**
Table 2 e PSQI scores of the good glycaemic control and poor glycaemic control patients
PSQI factors Good glycaemic control (n ¼ 50) Poor glycaemic control (n ¼ 156) Z value p value
Subjective sleep quality 0.90 ± 0.54 1.47 ± 0.74 4.78 0.001**
Sleep latency 0.82 ± 0.63 1.74 ± 1.11 5.13 0.001**
Sleep duration 0.64 ± 0.66 1.24 ± 1.10 3.26 0.001**
Sleep efficiency 0.30 ± 0.58 1.03 ± 1.14 4.01 0.001**
Sleep disturbance 1.06 ± 0.31 1.50 ± 0.54 5.17 0.001**
Use of sleeping medications 0.10 ± 0.51 0.21 ± 0.73 1.03 0.229
Daytime dysfunction 1.14 ± 0.83 2.19 ± 0.78 6.94 0.001**
Overall 4.96 ± 2.46 9.37 ± 3.97 7.08 0.001**
**p < 0.01.
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sleep quality of patients with type 2 diabetes was evaluated
using PSQI 8 as the cutting point. The results showed that
the incidence rate of sleep disorder in patients with type 2
diabetes was 47.1%, which is much higher than that in the
general population [16,17]. Nevertheless, this value is lower
than the reported values in other studies, which were 71.0%,
69.0%, and 73.9% [18e20]. A potential explanation is that our
PSQI cut-off value was higher than that in other reports,
potentially lowering the chance to recognize sleep disorder.
Meanwhile, the wide age range of our participants may have
affected the results, since age is a known factor that can
affect sleep. While most of the mentioned studies focused
only the senior citizens. All of this taken together could have
been responsible for the comparatively low incidence rate of
sleep disorder among our participants.
4.2. The impact of sleep quality on glycaemic control in
patients with type 2 diabetes
A life style such as smoking, drinking, blood glucose moni-
toring, and exercise, as well as, metabolic indicators (blood
pressure and lipids) did not seem to have a statistically sig-
nificant influence on the glycaemic control. This finding is
consistent with the previously published results [21]. Gener-
ally, nearly half of the patients with the painful diabetic
neuropathy suffer from sleep disorder [22]. However, most of
our participants who had diabetic neuropathy experienced
only minor symptoms (coldness or numbness of the limbs)
which had a minimal effect on sleep. Plus, the duration ofTable 3 e Logistic regression analysis of the PSQI score
and glycaemic control
PSQI factors HbA1c  7%
b value SD OR 95% CI p value
Subjective sleep
quality
0.28 0.41 1.32 0.59e2.96 0.501
Sleep latency 0.76 0.28 2.14 1.26e3.69 0.006**
Sleep duration 0.19 0.30 0.83 0.46e1.47 0.522
Sleep efficiency 0.16 0.34 1.18 0.60e2.31 0.628
Sleep disturbance 1.63 0.63 5.09 1.48e17.52 0.034*
Use of sleeping
medications
0.14 0.41 0.87 0.39e1.94 0.733
Daytime
dysfunction
1.25 0.28 3.50 2.02e6.07 0.002**
*p < 0.05; **p < 0.01.diabetic neuropathy was short. Thus, no statistical significant
difference was found in the PSQI global score between those
with and without diabetic neuropathy. There was, however, a
statistically significant difference in the PSQI global score be-
tween those who maintained a good glycaemic control and
participants with poor glycaemic control with the latter group
having a far higher PSQI global score. The only PSQI factor not
showing a statistically significant difference between these
two groups was the “use of sleeping medications”. Those
participants with sleep disorders had a significantly higher
FPG, 2hPG, and HbA1c (all p < 0.05). This finding further sug-
gests that sleep disorder in diabetic patients can lead to an
elevated blood glucose, a poor glycaemic control [21,23]. Un-
like most of the mammals, humans can sleep in a single 7 e
9 h stretch, during which the reactivity of insulin b cell and
insulin sensitivity may be affected. Sleep has been shown to
regulate glucose tolerance and its dynamic balance. Conse-
quently, various types of sleep disorder can affect glucose
tolerance. The circadian regulation of sleep plays a significant
role in the production of insulin, insulin sensitivity, and
glucose consumption [24]. There is evidence showing that a
lack of 3 h sleep could lead to 1.1% elevation of HbA1c during
one single night. With 0.5 increase in PSQI global score, the
HbA1c can increase by 1.9%. [25]
The PSQI factor “sleep efficiency” is one of the components
that can influence glycaemic control [26]. A previously pub-
lished study suggests negative correlation betweenHbA1c and
sleep efficiency [27]. Nevertheless, no significant association
was found between sleep efficiency and glycaemic control in
this study. The difference might come from variations in
the sample size and the corresponding sleep quality
measurement tools. As indicated by the logistic regression
analysis, sleep latency, sleep disturbance, and daytime
dysfunction are the risk factors for poor glycaemic control.
Their OR (95% CI) are 2.14 (1.26e3.69), 5.09 (1.48e17.52), and
3.50 (2.02e6.07), respectively. These values indicate that with
one increase in the score of sleep latency, sleep disturbance
and daytime dysfunction, the risk for poor glycaemic control
would increase 2.14, 5.09, and 3.50 times, respectively. In
conclusion, the sleep in patients with type 2 diabetes plays a
decisive role in the glycaemic control.
The fundamental treatment for diabetes lies in a good
glycaemic control, the core measure for delaying the devel-
opment of diabetes. Some researchers proposed that
improving sleep quality, treating sleep disorder, and opti-
mizing sleep duration could be used as a regimen to indi-
rectly promote the glycaemic control [5,25]. HbA1c has long
i n t e r n a t i o n a l j o u rn a l o f n u r s i n g s c i e n c e s 1 ( 2 0 1 4 ) 2 6 0e2 6 5264been seen as the golden standard for assessing glycaemic
control. In this study, the HbA1c levels were measured in 206
patients with type 2 diabetes. Alarmingly, only 24.3% of the
participants had a good glycaemic control, which supports
other studies where merely 39.1% and 15.5% of the patients
maintained good glycaemic control [26,28]. All of these re-
sults suggest that at present a large number of diabetic pa-
tients do not have a good glycaemic control representing a
huge challenge for the effective management of diabetes for
the future.
No significant difference was found in terms of the “use of
sleepingmedications”between thegoodglycaemic control and
poor glycaemic control. This finding is similar to the result re-
ported by Zhi-Qiang Li et al. [29] The reason for this phenom-
enon is that most of the participants chose not to use the
hypnotics because of the drug side effects. Our participants
chose more traditional methods to manage their sleep. These
alternative approaches (exercise, drinking hot milk and foot
bath) lack the side-effects associated with sleep medications
and most likely contributed to lower usage of sleep medica-
tions. [30]
4.3. Limitations of the study
Unlike foreign studies, our study used the convenience sam-
pling method to only recruit participants from the hospitals,
potentially causing the difference in sleep disorder from foreign
studies. In the future research, a more rigorous sampling
method can be introduced to improve the generalization of the
results. Furthermore, a subjectivemethodwas used to evaluate
the sleep quality possibly lowering the objectivity of this study.
Amore objectivemethod, for example polysomnography, could
be combined with a subjective method providing a more satis-
fying study. Additionally, although the results in this study
indicated that the sleep quality can affect glycaemic control in
patients with type 2 diabetes, no further interventions were
given to those who suffered from sleep disorder.
Compared with the general population, diabetic people
experience a higher prevalence of sleep disorder further
exerting detrimental influence on glycaemic control. Our
findings provide basis for verifying the inter-relationship be-
tween sleep and glycaemic control. In the future clinical
practice, health care providers should pay attention to the
early recognition of sleep disorder in diabetic patients so that
corresponding measures could be taken to improve patient's
sleep quality in a timely fashion, thereby facilitating man-
agement of diabetes.Conflict of interest
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